HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

L Machet Selected Research

L Machet Research Topics

Disease

4Melanoma (Melanoma, Malignant)
01/2018 - 12/2006
4Neoplasms (Cancer)
03/2014 - 05/2006
3Pemphigus (Pemphigus Vulgaris)
01/2020 - 01/2005
3Vasculitis (Vasculitides)
06/2010 - 08/2002
2Breast Neoplasms (Breast Cancer)
11/2017 - 05/2014
2Drug Hypersensitivity Syndrome
11/2016 - 02/2008
2Acute Generalized Exanthematous Pustulosis
03/2014 - 05/2000
2Wounds and Injuries (Trauma)
12/2013 - 08/2004
2Ulcer
10/2013 - 08/2004
2Ewing Sarcoma (Sarcoma, Ewing)
04/2012 - 05/2011
2Urticaria (Hives)
06/2010 - 04/2001
2Hypersensitivity (Allergy)
02/2008 - 01/2000
2Lymphedema (Milroy Disease)
08/2004 - 12/2003
1Dowling-Degos Disease
12/2018
1Dermatitis
11/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2016
1Brain Neoplasms (Brain Tumor)
01/2016
1Mycosis Fungoides
10/2015
1Hyperhidrosis
03/2015
1Necrosis
11/2014
1Thrombocytopenia (Thrombopenia)
03/2014
1Vitamin D Deficiency
03/2014
1Skin Diseases (Skin Disease)
12/2013
1Superinfection
12/2013
1Infections
12/2013
1Necrobiosis Lipoidica
10/2013
1Acantholysis
08/2013
1Oral Ulcer (Mouth Ulcer)
02/2013
1Merkel Cell Carcinoma
04/2012
1Margins of Excision
05/2011
1Hemangiosarcoma (Angiosarcoma)
07/2010
1Familial dermographism
06/2010
1Angioedema
06/2010
1Rosacea (Acne Rosacea)
10/2008
1Erythema
10/2008
1Stomatodynia
02/2008
1Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos)
11/2007
1Fasciitis (Fascitis)
10/2007
1Polyarteritis Nodosa (Periarteritis Nodosa)
08/2006
1Viremia
08/2006
1Neuroblastoma
05/2006

Drug/Important Bio-Agent (IBA)

8Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 - 08/2002
4Pharmaceutical PreparationsIBA
11/2016 - 02/2008
3AntibodiesIBA
08/2013 - 08/2002
2Rituximab (Mabthera)FDA Link
01/2020 - 03/2005
2Immunoglobulin G (IgG)IBA
08/2013 - 01/2005
2Interferon-alpha (Interferon Alfa)IBA
08/2006 - 03/2006
1SteroidsIBA
01/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1Nonsense Codon (Nonsense Mutation)IBA
12/2018
1Immune Checkpoint InhibitorsIBA
01/2018
1IpilimumabIBA
01/2016
1Indicators and Reagents (Reagents)IBA
01/2016
1Infliximab (Remicade)FDA Link
01/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2015
1Tumor Necrosis Factor InhibitorsIBA
11/2014
125-hydroxyvitamin DIBA
03/2014
1Acetazolamide (Diamox)FDA LinkGeneric
03/2014
1Vitamin DFDA LinkGeneric
03/2014
1Calcitriol Receptors (Calcitriol Receptor)IBA
03/2014
1Anti-Bacterial Agents (Antibiotics)IBA
12/2013
1Local Anti-Infective Agents (Antiseptics)IBA
12/2013
1Platelet-Derived Growth FactorIBA
10/2013
1Becaplermin (PDGF-BB)FDA Link
10/2013
1Penicillamine (Cuprimine)FDA Link
08/2013
1Complement C3 (C3 Complement)IBA
08/2013
1Desmoglein 1IBA
08/2013
1tocilizumab (atlizumab)FDA Link
02/2013
1Bevacizumab (Avastin)FDA Link
07/2010
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2010
1AllergensIBA
06/2010
1cetrorelix (Cetrotide)FDA Link
10/2008
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2008
1Isotretinoin (Accutane)FDA LinkGeneric
10/2008
1follitropin alfa (Gonal F)FDA Link
10/2008
1Follicle Stimulating Hormone (Follitropin)FDA Link
10/2008
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2007
1Antiviral Agents (Antivirals)IBA
08/2006
1InterferonsIBA
08/2006
1Ribavirin (Virazole)FDA LinkGeneric
08/2006
1Complementary DNA (cDNA)IBA
05/2006
1Heparin (Liquaemin)FDA LinkGeneric
05/2006
1Topoisomerase I InhibitorsIBA
05/2006
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2006
1Irinotecan (Camptosar)FDA LinkGeneric
05/2006
1pleiotrophin (HARP)IBA
05/2006

Therapy/Procedure

12Therapeutics
11/2014 - 01/2000
3Radiotherapy
11/2017 - 12/2006
2Drug Therapy (Chemotherapy)
05/2014 - 08/2013
2Cryosurgery
12/2006 - 01/2000
1Segmental Mastectomy (Lumpectomy)
11/2017
1Sympathectomy (Sympathectomies)
03/2015
1Biological Therapy
11/2014
1Duration of Therapy
11/2014
1Topical Administration
12/2013
1Adjuvant Chemotherapy
05/2011
1Adjuvant Radiotherapy
05/2011
1Transplantation
01/2010
1Prostheses and Implants (Prosthesis)
02/2008
1Oral Diagnosis (Oral Examination)
11/2007